Navigation Links
Rigel Announces Third Quarter 2012 Financial Results
Date:11/6/2012

SOUTH SAN FRANCISCO, Calif., Nov. 6, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the three and nine months ended September 30, 2012.

For the third quarter of 2012, Rigel reported a net loss of $25.5 million, or $0.36 per share, compared to a net loss of $17.9 million, or $0.25 per share, in the same period of 2011. Weighted average shares outstanding for the third quarters of 2012 and 2011 were 71.6 million and 71.2 million, respectively.

There were no contract revenues from collaborations in the third quarter of 2012. Contract revenues from collaborations in the third quarter of 2011 were $4.4 million, which consisted of a $4.3 million payment from Merck Serono S.A.

Rigel reported total operating expenses of $25.6 million in the third quarter of 2012, compared to $22.4 million for the same period in 2011. The increase in operating expenses was primarily due to increased costs related to the clinical trials of R343, Rigel's inhaled SYK inhibitor program for asthma; R548, Rigel's oral JAK3 inhibitor program for transplant rejection; and R333, Rigel's topical JAK/SYK inhibitor program for discoid lupus.

For the nine months ended September 30, 2012, Rigel reported a net loss of $73.4 million, or $1.03 per basic and diluted share, compared to a net loss of $60.2 million, or $0.99 per basic and diluted share, for the same period of 2011.

As of September 30, 2012, Rigel had cash, cash equivalents and available for sale securities of $183.9 million, compared to $247.6 million as of December 31, 2011.  In October 2012, Rigel completed an underwritten public offering in which it sold an aggregate of 15,237,750 shares of common stock pursuant to an effective registration statement at a price to the public of $9.50 per share. Rigel received net proceeds of approximately $135.7
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
(Date:7/2/2015)... 2, 2015 Numotion,s Board of Directors and ... Tamas Feitel has joined the Company as ... a highly successful 18 year career at GE serving ... profitability, and productivity to result in significant industry leading ... Chief Financial Officer for GE Healthcare Global Services, a ...
(Date:7/2/2015)... 2, 2015 The report "Silage ... Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), ... 2020", Silage Inoculants & Enzymes Market is expected to ... 4.0% from 2015 to 2020. Browse ... through 194 P ages and an ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... 2011 Thoratec Corporation (Nasdaq: THOR ), ... to save, support and restore failing hearts, today announced ... of directors.  "Bill brings tremendous skill, leadership, ... delighted to add him to our board of directors," ...
... 16, 2011  Angeion Corporation (NASDAQ: ANGN ) today ... ended October 31, 2011. Fourth Quarter ... the fourth quarter of 2010, sequentially up 22% from the ... million, compared to $888,000 in last year,s fourth quarter; ...
Cached Medicine Technology:Thoratec Announces Appointment of William A. Hawkins to Board of Directors 2Thoratec Announces Appointment of William A. Hawkins to Board of Directors 3Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 2Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 3Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 4Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 5Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 6Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 7Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 8Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 9Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 10Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 11Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 12
(Date:7/2/2015)... , ... July 02, 2015 , ... Following the recent ... the number of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a ... threats to American society right now," Becic said. "We must understand the magnitude of ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s important ... tips to promote the proper use of fireworks. , According to the U.S. Consumer ... fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing the ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... versatile smart light bulbs on the market. , According to the U.S. Department of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression ... compression socks designed for men. , For style that’s quick on its feet, ... routine. This is great news for men everywhere because a simple change in socks ...
(Date:7/2/2015)... ... July 02, 2015 , ... ActiveBunch.com recently launched as ... social fitness. Built to function as a lifestyle community, Active Bunch allows users to ... to network, meet, and participate in discussions or group events. , The spokesperson ...
Breaking Medicine News(10 mins):Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... of the Treatment Advocacy Center (TAC) selected attorney and,consumer ... the second since the organization was formed nine years ... November 10,2007. He will start January 2, 2008., ... president E. Fuller,Torrey. "TAC has firmly established itself as ...
... Parties Merry and Safe for Everyone, CHICAGO, Nov. ... the holidays it,s sometimes easy to forget that the ... can be a time when widespread,availability of alcohol at ... children may view these parties as,opportunities to sneak alcohol, ...
... Omnicell, Inc.,(Nasdaq: OMCL ) a leading provider ... efficiency in healthcare,facilities, today announced that Randall A. Lipps, ... CFO will present at the Piper Jaffray,19th Annual Health ... The,Omnicell presentation is scheduled to begin at 12:00 p.m. ...
... Current Revatrol formulation has 100MG of actual resveratrol plus 95% ... ... Fla., Nov. 19 Revatrol,s manufacturer,Renaissance Health Publishing, LLC, is ... wine supplements analyzes an,out-of-date formulation of Revatrol, and calls on ...
... smarter choice, study suggests , MONDAY, Nov. 19 (HealthDay News) ... infection, surgery to remove the tonsils is more expensive, but ... to see if symptoms resolve, a Dutch study finds. , ... Utrecht compared 151 children, ages 2 to 8, who were ...
... 19, 2007) -- Dr. Bruce McCandliss, a psychologist at ... of psychology in psychiatry at Weill Cornell Medical College, ... United States in the form of a Presidential Early ... is the highest honor bestowed by the U.S. government ...
Cached Medicine News:Health News:Kurt Entsminger Named Executive Director of Treatment Advocacy Center 2Health News:Holidays Can Present Drinking Opportunities for Teens 2Health News:Holidays Can Present Drinking Opportunities for Teens 3Health News:Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference 2Health News:ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing 2Health News:ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing 3Health News:Tonsillectomy Not Always Cost-Effective for Kids' Throat Woes 2Health News:White House awards Weill Cornell's Bruce McCandliss highest honor for early career scientists 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: